Hill Dermaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsHill Dermaceuticals

Hill Dermaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Dermotic	Fluocinolone	1988-02-03	2027-2030	Psoriasis , Atopic dermatitis , Pruritus , Inflammation , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Acne vulgaris , Promyelocytic leukemia acute , Hyperpigmentation , Bacterial infections , Bacterial skin diseases , Escherichia coli infections , Hepatic encephalopathy , Neutropenia , Prostatitis , Fever , Urinary tract infections , Sinusitis , Typhoid fever , Diarrhea , Gonorrhea , Intraabdominal infections , Pseudomonas infections , Osteomyelitis , Campylobacter infections , Bacterial conjunctivitis , Staphylococcal infections , Infectious arthritis , Pyelonephritis , Proteus infections , Anthrax , Klebsiella infections , Otitis externa , Haemophilus infections , Protozoan infections , Cystitis , Dysentery , Bacteroides infections
Tolak	Fluorouracil	2015-09-18		Breast neoplasms , Pancreatic neoplasms , Stomach neoplasms , Head and neck neoplasms , Basal cell carcinoma , Colonic neoplasms , Rectal neoplasms , Keratosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Antithrombin iii

healthy volunteers/patients

,

pharmacokinetics

,

biological availability

,

,

,

therapeutic equivalency

,

,

chronic kidney failure

,

drug interactions

,

,

,

non-small-cell lung carcinoma

,

ischemic stroke

,

replacement arthroplasty knee

,

bariatric surgery

,

,

renal cell carcinoma

,

kidney neoplasms

,

transient ischemic attack

,

cerebral infarction

,

ovarian neoplasms

,

fallopian tube neoplasms

,

ovarian epithelial carcinoma

,

,

venous thrombosis

,

acute coronary syndrome

,

prostatic neoplasms

,

,

,

renal insufficiency

,

,

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

,

myocardial infarction

,

,

rheumatic diseases

,

kidney diseases

,

respiratory distress syndrome

,

coronavirus infections

,

severe acute respiratory syndrome

,

,

transcatheter aortic valve replacement

,

,

breast neoplasms

,

gastrointestinal stromal tumors

,

multiple sclerosis

,

,

,

non-hodgkin lymphoma

,

,

diabetes mellitus

,

neoplasm metastasis

,

,

bacterial pneumonia

,

central nervous system diseases

,

nervous system diseases

,

thrombophlebitis

,

knee osteoarthritis

,

hip osteoarthritis

,

,

,

unstable angina

,

rheumatic heart disease

,

,

respiratory insufficiency

,

communicable diseases

,

collagen diseases

,

,

aortic valve stenosis

,

heart valve diseases

,

ventricular outflow obstruction

,

percutaneous coronary intervention

,

castration-resistant prostatic neoplasms

,

coronary disease

,

macular degeneration

,

chronic renal insufficiency

,

,

atrial fibrillation

,

thromboembolism

,

venous thromboembolism

,

,

,

pulmonary embolism

,

,

coronary artery disease

,

peripheral arterial disease

,

,

cardiovascular diseases

,

,

atherosclerosis

,

,

myocardial ischemia

,

respiratory tract diseases

,

embolism and thrombosis

,

,

,

carotid stenosis

,

peripheral vascular diseases

,

atherosclerotic plaque

,

intermittent claudication

,

,

antiphospholipid syndrome

,

,

vascular diseases

,

replacement arthroplasty hip

,

intracranial hemorrhages

,

disease progression

,

,

,

,

interstitial cystitis

,

,

congenital heart defects

,

fontan procedure

hemochromatosis

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use